Chun‐Yan Kong

2.3k total citations · 3 hit papers
31 papers, 1.8k citations indexed

About

Chun‐Yan Kong is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Chun‐Yan Kong has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Chun‐Yan Kong's work include Cardiac Fibrosis and Remodeling (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers) and Cardiovascular Function and Risk Factors (5 papers). Chun‐Yan Kong is often cited by papers focused on Cardiac Fibrosis and Remodeling (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers) and Cardiovascular Function and Risk Factors (5 papers). Chun‐Yan Kong collaborates with scholars based in China, United States and Poland. Chun‐Yan Kong's co-authors include Yu‐Pei Yuan, Zhen‐Guo Ma, Peng Song, Xin Zhang, Si‐Chi Xu, Qizhu Tang, Qi‐Zhu Tang, Can Hu, Hai‐Ming Wu and Wei Deng and has published in prestigious journals such as Nature Communications, Journal of Hazardous Materials and Free Radical Biology and Medicine.

In The Last Decade

Chun‐Yan Kong

26 papers receiving 1.8k citations

Hit Papers

FNDC5 alleviates oxidative stress and cardiomyocyte apopt... 2019 2026 2021 2023 2019 2021 2024 100 200 300

Peers

Chun‐Yan Kong
Can Hu China
Marina Bayeva United States
Rong Shao China
Yabing Chen United States
Khanh T. Nguyen United States
Chun‐Yan Kong
Citations per year, relative to Chun‐Yan Kong Chun‐Yan Kong (= 1×) peers Si‐Chi Xu

Countries citing papers authored by Chun‐Yan Kong

Since Specialization
Citations

This map shows the geographic impact of Chun‐Yan Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Yan Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Yan Kong more than expected).

Fields of papers citing papers by Chun‐Yan Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Yan Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Yan Kong. The network helps show where Chun‐Yan Kong may publish in the future.

Co-authorship network of co-authors of Chun‐Yan Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Yan Kong. A scholar is included among the top collaborators of Chun‐Yan Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Yan Kong. Chun‐Yan Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kong, Chun‐Yan, Zhen Guo, Pan Wang, et al.. (2025). Adamts1 Exacerbates Post‐Myocardial Infarction Scar Formation via Mechanosensing of Integrin α8. Advanced Science. 12(46). e04138–e04138.
4.
Kong, Chun‐Yan, Zhen Guo, Qi Yao, et al.. (2024). Electroactive Nanomaterials for the Prevention and Treatment of Heart Failure: From Materials and Mechanisms to Applications. Small. 20(49). e2406206–e2406206. 5 indexed citations
5.
Yuan, Yu‐Pei, Si‐Chi Xu, Chun‐Yan Kong, et al.. (2024). S100a8/9 (S100 Calcium Binding Protein a8/9) Promotes Cardiac Hypertrophy Via Upregulation of FGF23 (Fibroblast Growth Factor 23) in Mice. Journal of the American Heart Association. 13(10). e028006–e028006. 2 indexed citations
6.
Kong, Chun‐Yan, Zhen Guo, Pan Wang, et al.. (2024). Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis. Nature Communications. 15(1). 4757–4757. 45 indexed citations breakdown →
7.
Zhang, Xin, Can Hu, Zhen‐Guo Ma, et al.. (2023). Tisp40 prevents cardiac ischemia/reperfusion injury through the hexosamine biosynthetic pathway in male mice. Nature Communications. 14(1). 3383–3383. 44 indexed citations
8.
Kong, Chun‐Yan, Zhen Guo, Fang-Yuan Liu, et al.. (2023). Triad3A-Mediated K48-Linked ubiquitination and degradation of TLR9 impairs mitochondrial bioenergetics and exacerbates diabetic cardiomyopathy. Journal of Advanced Research. 61. 65–81. 9 indexed citations
9.
Teng, Teng, Chun‐Yan Kong, Rong Huang, et al.. (2022). Mapping current research and identifying hotspots of ferroptosis in cardiovascular diseases. Frontiers in Cardiovascular Medicine. 9. 1046377–1046377. 7 indexed citations
10.
Kong, Chun‐Yan, Zhen Guo, Peng Song, et al.. (2021). Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death. International Journal of Biological Sciences. 18(2). 760–770. 226 indexed citations breakdown →
11.
Zhang, Xin, Can Hu, Yu‐Pei Yuan, et al.. (2021). Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism. Cell Biology and Toxicology. 37(6). 873–890. 69 indexed citations
12.
Hu, Can, Xin Zhang, Peng Song, et al.. (2020). Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway. Redox Biology. 37. 101747–101747. 181 indexed citations
13.
Ma, Zhen‐Guo, Chun‐Yan Kong, Hai‐Ming Wu, et al.. (2020). Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice. Theranostics. 10(24). 11013–11025. 42 indexed citations
14.
Song, Peng, Zhi‐Gang She, Yanyan Meng, et al.. (2020). Geniposide protects against sepsis-induced myocardial dysfunction through AMPKα-dependent pathway. Free Radical Biology and Medicine. 152. 186–196. 61 indexed citations
15.
Zhang, Xin, Jinxiu Zhu, Zhen‐Guo Ma, et al.. (2019). Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity. International Journal of Biological Sciences. 15(3). 556–567. 114 indexed citations
16.
Zhang, Xin, Can Hu, Chun‐Yan Kong, et al.. (2019). FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death and Differentiation. 27(2). 540–555. 359 indexed citations breakdown →
17.
Li, Ning, Heng Zhou, Zhen‐Guo Ma, et al.. (2018). Geniposide Alleviates Isoproterenol-Induced Cardiac Fibrosis Partially via SIRT1 Activation in vivo and in vitro. Frontiers in Pharmacology. 9. 854–854. 48 indexed citations
18.
Ma, Zhen‐Guo, Chun‐Yan Kong, Peng Song, et al.. (2018). Geniposide Protects against Obesity‐Related Cardiac Injury through AMPKα‐ and Sirt1‐Dependent Mechanisms. Oxidative Medicine and Cellular Longevity. 2018(1). 6053727–6053727. 35 indexed citations
19.
Zhang, Xin, Zhen‐Guo Ma, Yu‐Pei Yuan, et al.. (2018). Rosmarinic acid attenuates cardiac fibrosis following long-term pressure overload via AMPKα/Smad3 signaling. Cell Death and Disease. 9(2). 102–102. 120 indexed citations
20.
Liu, Zhepeng, Shuliang Chen, Qiankun Wang, et al.. (2017). Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4+ T cells from HIV-1 infection. Cell & Bioscience. 7(1). 47–47. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026